Congress Video

Impact of age, Recurrence Score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

Published: 20 September 2022

Presentation from ESMO 2022, Paris

The mention of any company, product, service, or therapy in this collection of materials does not constitute an endorsement of any kind by ESMO.

Sign up for new content alerts

Enter your email address below and we'll contact you as soon as new content is launched!

Name(Required)

HCP confirmation(Required)

I confirm that I am a healthcare professional

I have read and accept the terms of the Privacy notice and the Terms and Conditions and consent to receive e-alerts from Springer Healthcare IME pertinent to my area of interest. I can withdraw my consent at any time by contacting [email protected] or via the ‘unsubscribe’ link included in any email communications

This field is for validation purposes and should be left unchanged.

News & Resources

Congress Video

Impact of age, Recurrence Score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

Published: 20 September 2022

Presentation from ESMO 2022, Paris

Sign up for new content alerts

Login / register

Can you spare 2 minutes to share some feedback?